132 related articles for article (PubMed ID: 36484373)
1. The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.
Aoki H; Bitnun A; Kitano T
J Med Virol; 2023 Jan; 95(1):e28391. PubMed ID: 36484373
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening and valacyclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France.
Périllaud-Dubois C; Hachicha-Maalej N; Lepers C; Letamendia E; Teissier N; Cousien A; Sibiude J; Deuffic-Burban S; Vauloup-Fellous C; Picone O
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):573-584. PubMed ID: 37099516
[TBL] [Abstract][Full Text] [Related]
3. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
4. Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis.
Fisher SA; Miller ES; Yee LM; Grobman WA; Premkumar A
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100676. PubMed ID: 35714861
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
[TBL] [Abstract][Full Text] [Related]
6. Disease burden of congenital cytomegalovirus infection in Japan.
Aoki H; Kitano T; Kitagawa D
J Infect Chemother; 2021 Feb; 27(2):161-164. PubMed ID: 32912713
[TBL] [Abstract][Full Text] [Related]
7. Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection.
Goncé A; Hawkins-Villarreal A; Salazar L; Guirado L; Marcos MA; Pascual Mancho J; Prats P; López M; Eixarch E; Salvia MD; Fortuny C; Figueras F
J Matern Fetal Neonatal Med; 2022 Oct; 35(20):4004-4008. PubMed ID: 33143511
[TBL] [Abstract][Full Text] [Related]
8. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study.
Bartlett AW; Hall BM; Palasanthiran P; McMullan B; Shand AW; Rawlinson WD
J Clin Virol; 2018 Nov; 108():121-125. PubMed ID: 30300787
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
Albright CM; Werner EF; Hughes BL
Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
[TBL] [Abstract][Full Text] [Related]
10. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme.
Beswick R; David M; Higashi H; Thomas D; Nourse C; Koh G; Koorts P; Jardine LA; Clark JE
J Paediatr Child Health; 2019 Nov; 55(11):1381-1388. PubMed ID: 30916438
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of neonatal hearing screening program in China: should universal screening be prioritized?
Huang LH; Zhang L; Tobe RY; Qi FH; Sun L; Teng Y; Ke QL; Mai F; Zhang XF; Zhang M; Yang RL; Tu L; Li HH; Gu YQ; Xu SN; Yue XY; Li XD; Qi BE; Cheng XH; Tang W; Xu LZ; Han DM
BMC Health Serv Res; 2012 Apr; 12():97. PubMed ID: 22510223
[TBL] [Abstract][Full Text] [Related]
12. Congenital Cytomegalovirus Infection: Epidemiology, Timely Diagnosis, and Management.
Jenks CM; Hoff SR; Mithal LB
Neoreviews; 2021 Sep; 22(9):e606-e613. PubMed ID: 34470762
[TBL] [Abstract][Full Text] [Related]
13. A cohort study of the universal neonatal urine screening for congenital cytomegalovirus infection.
Yamada H; Tanimura K; Fukushima S; Fujioka K; Deguchi M; Sasagawa Y; Tairaku S; Funakoshi T; Morioka I
J Infect Chemother; 2020 Aug; 26(8):790-794. PubMed ID: 32273174
[TBL] [Abstract][Full Text] [Related]
14. Universal neonatal cytomegalovirus screening using saliva - report of clinical experience.
Barkai G; Ari-Even Roth D; Barzilai A; Tepperberg-Oikawa M; Mendelson E; Hildesheimer M; Kuint J
J Clin Virol; 2014 Aug; 60(4):361-6. PubMed ID: 24881490
[TBL] [Abstract][Full Text] [Related]
15. Congenital cytomegalovirus infection.
Fowler KB; Boppana SB
Semin Perinatol; 2018 Apr; 42(3):149-154. PubMed ID: 29503048
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection during pregnancy: state of the science.
Leruez-Ville M; Foulon I; Pass R; Ville Y
Am J Obstet Gynecol; 2020 Sep; 223(3):330-349. PubMed ID: 32105678
[TBL] [Abstract][Full Text] [Related]
17. The Yield of Targeted Examination for the Detection of Symptomatic Congenital Cytomegalovirus Infection.
Masarweh K; Felszer-Fisch C; Shinwell E; Hasanein J; Peniakov M; Weiner SA; Lurye-Marcu B; Miron D
Isr Med Assoc J; 2021 May; 23(5):318-322. PubMed ID: 34024050
[TBL] [Abstract][Full Text] [Related]
18. Hearing outcomes in children with congenital cytomegalovirus infection: From management controversies to lack of parents' knowledge.
Aldè M; Caputo E; Di Berardino F; Ambrosetti U; Barozzi S; Piatti G; Zanetti D; Pignataro L; Cantarella G
Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111420. PubMed ID: 36563581
[TBL] [Abstract][Full Text] [Related]
19. Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-III maternity cohort.
Letamendia-Richard E; Périllaud-Dubois C; de La Guillonnière L; Thouard I; Cordier AG; Roque-Afonso AM; de Luca D; Benachi A; Vauloup-Fellous C
BJOG; 2022 Jan; 129(2):291-299. PubMed ID: 34726316
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a flow chart for targeted screening of congenital cytomegalovirus-related hearing loss.
Ciccia M; Monari C; Vitagliano G; Zarro N; Sandri F
J Neonatal Perinatal Med; 2018; 11(3):339-343. PubMed ID: 30040746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
